SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-001617
Filing Date
2021-01-06
Accepted
2021-01-06 17:25:18
Documents
14
Period of Report
2020-10-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2038985d1_8ka.htm   iXBRL 8-K/A 38031
2 EXHIBIT 23.1 tm2038985d1_ex23-1.htm EX-23.1 2476
3 EXHIBIT 99.3 tm2038985d1_ex99-3.htm EX-99.3 398029
  Complete submission text file 0001104659-21-001617.txt   642985

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA gild-20201023.xsd EX-101.SCH 3181
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20201023_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20201023_pre.xml EX-101.PRE 22707
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2038985d1_8ka_htm.xml XML 3494
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Filer) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19731 | Film No.: 21511799
SIC: 2836 Biological Products, (No Diagnostic Substances)